Monday - October 24, 2016

Bayer partnership with Plunket to benefit families

Plunket’s community support services are set to receive a boost thanks to Bayer New Zealand and the very community Plunket serves – children and their families

Auckland, October, 2016Plunket’s community support services are set to receive a boost thanks to Bayer New Zealand and the very community Plunket serves – children and their families.


Plunket has given Bayer products Bepanthen Nappy Rash, Bepanthen Antiseptic Cream, and Elevit Breastfeeding Pick Me Help Plunket status.


For every one of these products sold, Plunket will receive a percentage of the sales which will go straight back into providing and bolstering community support services.


“As a father of two babies I’m absolutely over the moon. I know first-hand the wonderful services that Plunket provides to parents – I’m delighted that we are able to redirect a share of our sales straight back into supporting the community,” says Anish Patel, who heads Bayer’s Consumer Health division in New Zealand.


“The great aspect of this partnership is that it’s about the people who benefit the most from Plunket – new parents and their babies.


“People always have a choice, but through buying Pick Me Help Plunket products they know they’re also directly helping Plunket and the overall wellbeing of children.”


Anish says Bayer wanted to be able to support the great work that Plunket does, while at the same time reaching out to the community with some great products.


“Bepanthen has been healing skin for more than 70 years – it’s a product many parents with babies and children are already familiar with.


“On the other hand, we have Elevit Breastfeeding – a new product that has been especially formulated to support a woman’s increased nutritional needs during breastfeeding.

“It’s a great fit really. Bayer is the second largest supplier of non-prescription medicines and dietary supplements in the world, while Plunket is New Zealand’s largest provider of Well Child Tamariki Ora services to children under the age of five.


“Our new partnership is not only mutually beneficial, but will also contribute to the wellbeing of New Zealand children and their families– you can’t ask for more than that in a relationship.”


Plunket says the partnership with Bayer will help the organisation continue to provide valuable community services to families around New Zealand for free.


“It’s very exciting to have Bayer as a partner. Like us, the Bayer brand has been around for years and is well known in New Zealand. It’s wonderful that we’re able to work together to help and support families,” says Plunket National Fundraising Manager, Carolyn Mettrick.





William Malpass, phone 021 935 217



Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to



Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.